BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
89.67
-1.62 (-1.77%)
At close: Oct 22, 2026, 4:00 PM EDT
89.00
-0.67 (-0.75%)
After-hours: Oct 22, 2026, 7:42 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.53 billion as of October 22, 2026. It is the 1,077th most valuable company in the world and the 448th biggest in the United States. Its market cap has decreased by 12.34% in one year.
Market Cap
22.53B
Enterprise Value
7.50B
1-Year Change
-12.34%
Global Rank
Country Rank
#448 United States
Category
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.53B, an increase of 652.11%. That is a compound annual growth rate of 33.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 22.53B | -1.60% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 35.74B |
| Alnylam Pharmaceuticals | 30.12B |
| Roivant Sciences | 26.58B |
| Genmab | 23.51B |
| Incyte | 22.99B |
| Insmed | 20.54B |
| Exelixis | 16.00B |
| Ascendis Pharma | 15.69B |